Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | 1 | IL-2 | 49.0 | 33 | |||||||
0 | IL-2 | 42.5 | 80 | ||||||||
0 | IL-2 | 44.0 | 43 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 1 | IL-2 | 73.0 | 57 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 65.0 | 72 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 61.0 | 75 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 59.0 | 83 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 69.5 | 74 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 54.0 | 76 | |
RA2159 | EO1428 | 1.0 | uM | 1 | IL-2 | 38.5 | 78 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | IL-2 | 71.0 | 75 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 85.5 | 80 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 74.0 | 79 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 78.0 | 58 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 70.5 | 74 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL-2 | 66.0 | 71 | |
N2586 | EO1428 | 1.0 | uM | 1 | IL-2 | 47.0 | 46 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | IL-2 | 70.0 | 83 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-2 | 68.0 | 82 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-2 | 46.0 | 79 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-2 | 68.0 | 75 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-2 | 73.0 | 69 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL-2 | 41.0 | 68 | |
RA2159 | PI103 | 0.1 | uM | 1 | IL-2 | 39.0 | 68 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | IL-2 | 82.0 | 60 |